EchoGo
JSON twin: https://www.healthaidb.com/software/echogo.json
Company Name
Ultromics
Product URL
https://www.ultromics.com/products/echogo
Company URL
https://www.ultromics.com
Categories
Summary
EchoGo® Amyloidosis is an AI-driven diagnostic tool by Ultromics that enhances early detection of cardiac amyloidosis using standard echocardiogram images.
Description
EchoGo® Amyloidosis is an AI-powered software designed to improve the early detection of cardiac amyloidosis, a condition often underdiagnosed as a cause of heart failure. Utilizing standard echocardiogram images, it analyzes a single apical 4-chamber view to identify potential cases with high accuracy. The device has demonstrated 84.5% sensitivity and 89.7% specificity in detecting cardiac amyloidosis among individuals aged 65 and older with heart failure. It integrates seamlessly into existing clinical workflows, requiring no additional hardware and operating on a Software-as-a-Service (SaaS) model, making it highly scalable and rapidly deployable. EchoGo® Amyloidosis complements Ultromics' existing EchoGo® Heart Failure device, providing a comprehensive solution for diagnosing heart failure and its underlying causes. The device has received FDA clearance and is supported by reimbursement pathways, including Category III CPT Code 0932T for outpatient settings, effective January 1, 2025.
Api Available
yes
Certifications
- FDA 510(k) clearance (EchoGo Pro)
- CE mark
- ISO 27001
- ISO 13485
Company Founding
2017
Company Offices
Compliance
- HIPAA
- GDPR
- UK Data Protection regulations
Customers
Data Residency
Cloud regions available (UK/EU and US cloud hosting options)
Data Standards
Deployment Model
Features
- Automated echocardiography quantification (LV volumes, LVEF)
- Automated global longitudinal strain measurement
- Stress-echocardiography CAD detection (EchoGo Pro module)
- HFpEF detection and risk prediction
- Cardiac amyloidosis detection module
- AI-driven diagnostic decision support and risk scores
- Vendor-neutral DICOM ingest and PACS connectivity
- Automated report generation (cloud-based)
- Batch processing / high-throughput analysis
- Clinical analytics and outcomes reporting
- Quality control and image triage assistance
- Clinician user interface with visual overlays and measurements
Id
SW2822
Integration Partners
Integrations
- PACS (DICOM)
- Hospital EHR / EMR systems
- RIS/reporting systems
- DICOM modalities (ultrasound vendors)
- Clinical workflow systems / reporting viewers
Languages Supported
Last Updated
2025-10-11
License
Commercial
Market Segment
Optional Modules
- EchoGo Pro module
- Cardiac amyloidosis detection module
Os Platforms
Pricing Details
Contact vendor for pricing information.
Pricing Model
Subscription
Privacy Features
- BAA available
- Consent management
- Anonymization
- Data minimization
Product Code
SW2822
Product Name
EchoGo
Ratings
Regions Available
Related Urls
Release Year
Security Features
- Data encryption in transit and at rest
- Role-based access control (RBAC)
- SSO/SAML support
- Audit logging
- Multi-factor authentication (MFA/2FA)
Specialties
Support Channels
System Requirements
Modern web browser; cloud-hosted service (no on-prem server required for SaaS use)
Target Users
- Clinicians
- Cardiologists
- Healthcare Providers
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "EchoGo",
"company_name": "Ultromics",
"product_url": "https://www.ultromics.com/products/echogo",
"company_url": "https://www.ultromics.com",
"related_urls": [],
"product_code": "SW2822",
"summary": "EchoGo® Amyloidosis is an AI-driven diagnostic tool by Ultromics that enhances early detection of cardiac amyloidosis using standard echocardiogram images.",
"description": "EchoGo® Amyloidosis is an AI-powered software designed to improve the early detection of cardiac amyloidosis, a condition often underdiagnosed as a cause of heart failure. Utilizing standard echocardiogram images, it analyzes a single apical 4-chamber view to identify potential cases with high accuracy. The device has demonstrated 84.5% sensitivity and 89.7% specificity in detecting cardiac amyloidosis among individuals aged 65 and older with heart failure. It integrates seamlessly into existing clinical workflows, requiring no additional hardware and operating on a Software-as-a-Service (SaaS) model, making it highly scalable and rapidly deployable. EchoGo® Amyloidosis complements Ultromics' existing EchoGo® Heart Failure device, providing a comprehensive solution for diagnosing heart failure and its underlying causes. The device has received FDA clearance and is supported by reimbursement pathways, including Category III CPT Code 0932T for outpatient settings, effective January 1, 2025.",
"categories": [
"clinical Care",
"diagnostic Support",
"cardiology",
"ai Clinical Documentation Integrity",
"clinical Decision Support",
"imaging Software",
"Clinical",
"Diagnostic",
"Cardiology",
"Artificial Intelligence",
"Medical Imaging"
],
"market_segment": [
"Enterprise",
"SMB"
],
"target_users": [
"Clinicians",
"Cardiologists",
"Healthcare Providers"
],
"specialties": [
"Cardiology",
"Heart Failure",
"Echocardiography"
],
"regions_available": [
"United States",
"United Kingdom",
"European Union"
],
"languages_supported": [
"English"
],
"pricing_model": "Subscription",
"pricing_details": "Contact vendor for pricing information.",
"license": "Commercial",
"company_offices": [
"United Kingdom",
"United States"
],
"company_founding": "2017",
"deployment_model": [
"SaaS"
],
"os_platforms": [
"Web"
],
"features": [
"Automated echocardiography quantification (LV volumes, LVEF)",
"Automated global longitudinal strain measurement",
"Stress-echocardiography CAD detection (EchoGo Pro module)",
"HFpEF detection and risk prediction",
"Cardiac amyloidosis detection module",
"AI-driven diagnostic decision support and risk scores",
"Vendor-neutral DICOM ingest and PACS connectivity",
"Automated report generation (cloud-based)",
"Batch processing / high-throughput analysis",
"Clinical analytics and outcomes reporting",
"Quality control and image triage assistance",
"Clinician user interface with visual overlays and measurements"
],
"optional_modules": [
"EchoGo Pro module",
"Cardiac amyloidosis detection module"
],
"integrations": [
"PACS (DICOM)",
"Hospital EHR / EMR systems",
"RIS/reporting systems",
"DICOM modalities (ultrasound vendors)",
"Clinical workflow systems / reporting viewers"
],
"data_standards": [
"DICOM",
"HL7",
"FHIR"
],
"api_available": "yes",
"system_requirements": "Modern web browser; cloud-hosted service (no on-prem server required for SaaS use)",
"compliance": [
"HIPAA",
"GDPR",
"UK Data Protection regulations"
],
"certifications": [
"FDA 510(k) clearance (EchoGo Pro)",
"CE mark",
"ISO 27001",
"ISO 13485"
],
"security_features": [
"Data encryption in transit and at rest",
"Role-based access control (RBAC)",
"SSO/SAML support",
"Audit logging",
"Multi-factor authentication (MFA/2FA)"
],
"privacy_features": [
"BAA available",
"Consent management",
"Anonymization",
"Data minimization"
],
"data_residency": "Cloud regions available (UK/EU and US cloud hosting options)",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "",
"integration_partners": [],
"id": "SW2822",
"slug": "echogo",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/echogo.json"
}
}